Law360, New York (December 03, 2007, 12:00 AM ET) -- The battle over whether to certify a dental monitoring class in the Fosamax case took center stage on Friday as plaintiffs' attorneys pushed the judge to grant class status to those patients who have yet to develop the painful jaw condition that is allegedly linked to the osteoporosis medication.
Lead plaintiffs attorney Timothy O'Brien argued before U.S. District Judge John Keenan in Mahattan district court last week about the importance of the class bid, maintaining that hundreds of thousands of patients would benefit from the additional...
Tug-Of-War Over Fosamax Class Continues
To view the full article, take a free trial now.
